Reminder: December 7th, Saturday (5p-7p): Quarterly Business & Educational Meeting sponsored by Teva Pharmaceuticals "Etiology, Diagnosis, and Assessment of Tardive Dyskinesia" at Mediterrano in Ann Arbor

Register on front page of website or use this link December 7th, Saturday (5p-7p): Quarterly Business & Educational Meeting sponsored by Teva Pharmaceuticals "Etiology, Diagnosis, and Assessment of Tardive Dyskinesia" at Mediterrano in Ann Arbor | The Great Lakes Chapter of GAPNA | ENP Network

5p-6p - Educational presentation
6p-7p - Business meeting

The Etiology, Diagnosis, and Assessment of Tardive Dyskinesia

Saturday, December 7, 2024

5:00 - 7:00 PM EST 

Mediterrano

2900 South State Street
Ann Arbor, MI 48104

DELIVERED BY: 

     Courtney Leinen, PMHNP-BC, Clinical Science Liaison, Teva Pharmaceuticals

The primary educational topics include:

• Education on the definition, pathophysiology, diagnostic criteria, clinical presentation, risk factors, burden of disease, and incidence/prevalence rate of TD
• Information for how changes in movements caused by TD are captured on the AIMS scale
• A visual illustration of patients with TD undergoing an AIMS assessment by a movement disorder specialist, for HCPs to visualize different severities of TD and the AIMS scores in different parts of the body affected by TD
• A visual illustration of patients with TD performing activities of daily living

 

Teva Pharmaceuticals strictly adheres to PhRMA guidelines, and we will therefore be unable to accept guests at this program. Space is limited. We urge you to register as quickly as possible to secure your place at the program.

 This is an industry program from Teva Pharmaceuticals, and is not a CME program.